Approval · Notice of Compliance 35596 · 2025
RINGZA: Notice of Compliance 35596
Issued June 27, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35596
- Date
- June 27, 2025
- Company
- Duchesnay Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RINGZA | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 17.4 MG per RING
- SEGESTERONE ACETATE 103 MG per RING